COMMON STOCK PURCHASE WARRANT VIRAL GENETICS, INC.Common Stock Purchase Warrant • December 9th, 2005 • Viral Genetics Inc /De/ • Pharmaceutical preparations
Contract Type FiledDecember 9th, 2005 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Robert Siegel, MD, an individual residing in the city of Pleasantville, New York, (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the three year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Viral Genetics, Inc., a Delaware corporation (the “Company”), up to 555,555 shares (the “Warrant Shares”) of Common Stock, par value $0.0001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT VIRAL GENETICS, INC.Common Stock Purchase Warrant • October 24th, 2005 • Viral Genetics Inc /De/ • Pharmaceutical preparations
Contract Type FiledOctober 24th, 2005 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, , a, (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the three year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Viral Genetics, Inc., a Delaware corporation (the “Company”), up to shares (the “Warrant Shares”) of Common Stock, par value $0.0001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).